Trials / Conditions / Schizo Affective Disorder

Schizo Affective Disorder

81 registered clinical trials studyying Schizo Affective Disorder — 17 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA NCT06474325	University of Pittsburgh	N/A
Not Yet Recruiting	REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health) NCT07006935	Case Western Reserve University	N/A
Recruiting	Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways NCT07469384	Nathan Kline Institute for Psychiatric Research	N/A
Recruiting	Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder NCT07213466	Mayo Clinic	Phase 4
Recruiting	Visual Perception in Schizophrenia NCT06911931	University of Rochester	N/A
Unknown	Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psycho NCT06643871	Centre Hospitalier St Anne	N/A
Recruiting	Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy NCT06529029	Michigan State University	Phase 2 / Phase 3
Unknown	Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate NCT06340789	National Cheng-Kung University Hospital	Phase 2
Recruiting	Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia NCT06174116	University of Massachusetts, Worcester	Phase 4
Active Not Recruiting	Young Adults With Violent Behavior During Early Psychosis (Aim 2) NCT05756855	Columbia University	N/A
Recruiting	Getting Out of the House: Using Behavioral Activation to Increase Community Participation NCT06336616	Temple University	N/A
Unknown	Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in NCT06176456	Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev	N/A
Completed	Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Di NCT06041646	BioXcel Therapeutics Inc	Phase 4
Completed	iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders NCT05899348	University of California, San Diego	N/A
Terminated	Accelerated rTMS for Psychomotor Slowing NCT06134661	University of Bern	N/A
Active Not Recruiting	Ketogenic Diet in People With Schizophrenia NCT05968638	University of Maryland, Baltimore	N/A
Completed	Technology-Assisted Implementation of a Mobile Health Program for Serious Mental Illness NCT05725785	University of Washington	N/A
Recruiting	Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis NCT05973110	The Royal Ottawa Mental Health Centre	N/A
Unknown	Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bip NCT06093451	Temple University	Phase 4
Recruiting	Critical Time Intervention-Peer Support NCT05945277	Lisbon Institute of Global Mental Health - LIGMH	N/A
Active Not Recruiting	EPI-MINN: Targeting Cognition and Motivation - National NCT05877716	University of Minnesota	N/A
Recruiting	iTBS to Enhance Social Cognition in People With Psychosis NCT06118268	Northwell Health	N/A
Completed	Causal Lesion Network Guided Treatment of Bipolar Mania With Transcranial Electrical Stimulation NCT05445466	Beth Israel Deaconess Medical Center	N/A
Suspended	D-serine AudRem: R33 Phase NCT05046353	New York State Psychiatric Institute	Phase 1 / Phase 2
Completed	The Efficacy of Neural Stimulation in Individuals With Schizophrenia NCT05746494	The University of Texas at Dallas	N/A
Completed	Remote State Representation in Early Psychosis NCT05538832	University of Minnesota	EARLY_Phase 1
Completed	CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies NCT05127837	University of Washington	N/A
Enrolling By Invitation	Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement NCT04323566	Uppsala University Hospital	Phase 2
Recruiting	Acetazolamide for Treatment Resistant Schizophrenia NCT04887792	Vishwajit Nimgaonkar, MD PhD	Phase 1 / Phase 2
Unknown	Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE) NCT04907279	Otsuka Canada Pharmaceutical Inc.	—
Completed	Targeting Individual Alpha Frequencies to Enhance Perceptual Timing NCT04856657	University of Minnesota	—
Completed	Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training NCT04005794	Vanderbilt University	N/A
Recruiting	Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia NCT05343598	Mclean Hospital	N/A
Completed	Brain Stimulation and Cognitive Training - Efficacy NCT05111548	University of Michigan	N/A
Recruiting	Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Di NCT05025605	BioXcel Therapeutics Inc	Phase 1
Unknown	Virtual Reality Avatar Therapy for People Hearing Voices NCT04099940	Psychiatric University Hospital, Zurich	N/A
Completed	Peripheral Immune System in Individuals With Schizophrenia NCT05109065	Stanford University	—
Completed	Efficacy Study of a New Individualized Rehabilitation Programme for Social Cognition in Patients With Schizoph NCT05130853	University of Campania Luigi Vanvitelli	N/A
Completed	Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagemen NCT04602741	Centre for Addiction and Mental Health	N/A
Unknown	Implementation, Efficacy and Costs of Inpatient Equivalent Home-Treatment in German Mental Health Care NCT04745507	Vivantes Netzwerk für Gesundheit GmbH	—
Completed	In-person vs. Remote Wellness Support NCT04526067	The University of Texas Health Science Center at San Antonio	N/A
Recruiting	Cognitive Training for Emotion Regulation in Psychotic Disorders NCT04414215	University of Georgia	N/A
Terminated	Models of Auditory Hallucination NCT04210557	Yale University	N/A
Completed	Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia NCT04268303	BioXcel Therapeutics Inc	Phase 3
Completed	Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis NCT04004416	University of Michigan	Phase 4
Completed	Transcranial Weak Current Stimulation Treatments for Working Memory Dysfunction in Schizophrenia NCT04637724	Oded Meiron	N/A
Completed	Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY) NCT04327843	Case Western Reserve University	Phase 3
Completed	Financial Incentives to Improve Medication Adherence NCT04191876	Northwell Health	N/A
Unknown	Bazedoxifene -Treatment for Women With Schizophrenia NCT04113993	The Alfred	Phase 4
Completed	Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders NCT03943537	Mclean Hospital	Phase 2
Withdrawn	L-arginine Study for Persistent Symptoms of Schizophrenia NCT04054973	University of Massachusetts, Worcester	Phase 2
Withdrawn	Repetitive Transcranial Magnetic Stimulation (rTMS) Self-Referential Processing (rTMS-SRP) NCT04068857	Indiana University	N/A
Completed	Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia NCT03648268	Beth Israel Deaconess Medical Center	N/A
Completed	Intervention Targeting Motivational Negative Symptoms NCT04325100	University of Liege	N/A
Unknown	DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currentl NCT03881449	Durham VA Medical Center	Phase 4
Recruiting	Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia NCT03794076	Vishwajit Nimgaonkar, MD PhD	Phase 1 / Phase 2
Completed	D-serine Augmentation of Neuroplasticity NCT03711500	New York State Psychiatric Institute	Phase 1 / Phase 2
Terminated	Telmisartan Pilot Study on Treatment Resistant Schizophrenia NCT03868839	Xiaoduo Fan	Phase 2
Completed	A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patie NCT03751488	Luye Pharma Group Ltd.	Phase 1
Completed	A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women NCT03774641	Johns Hopkins University	—
Completed	Brain Stimulation and Cognitive Training NCT03338673	University of Michigan	N/A
Completed	Cognitive Effects of Nimodipine in Patients With Schizophrenia NCT03671525	Johns Hopkins University	EARLY_Phase 1
Completed	Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness NCT03208036	VA Office of Research and Development	N/A
Completed	Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia NCT03860597	University of California, San Diego	Phase 4
Completed	Targeting Auditory Hallucinations With Alternating Current Stimulation NCT03221270	University of North Carolina, Chapel Hill	N/A
Terminated	A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders NCT03261817	University Hospital, Caen	N/A
Completed	Levetiracetam in Early Psychosis NCT03129360	NYU Langone Health	Phase 2
Completed	Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Le NCT03183609	University of Maryland, Baltimore	N/A
Unknown	Financial Incentives to Improve Acceptance of Antipsychotic Injections NCT03192631	Focus Community Mental Health Team	N/A
Completed	Mobile Enhancement of Motivation in Schizophrenia NCT03059771	Indiana University	N/A
Completed	Examining Persistence in Smokers With Schizophrenia NCT03346291	Rutgers, The State University of New Jersey	N/A
Completed	Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)- NCT02658357	Braeburn Pharmaceuticals	Phase 2
Completed	Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse NCT03558529	Manchester Academic Health Science Centre	—
Completed	Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels NCT01754532	Shalvata Mental Health Center	—
Completed	Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders NCT01720316	Mclean Hospital	Phase 2
Completed	Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients NCT01547026	University of Konstanz	N/A
Completed	A Shared Decision-making Training for Inpatients With Schizophrenia NCT02349880	Technical University of Munich	N/A
Terminated	Effects of Metformin and Fish Oil on Treatment With Clozapine NCT02140788	Duke University	Phase 4
Completed	Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis NCT01003132	University of Glasgow	N/A
Completed	Illness Management and Recovery for Veterans With Severe Mental Illness NCT00515671	VA Office of Research and Development	N/A
Completed	Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophreni NCT00463372	Pfizer	Phase 1